The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu

Recruiting

• Conditions: Helicobacter Pylori Infection

• Registration Number: NCT05654857
• Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Brief Summary

To assess Family-unit Helicobacter Pylori Infection rates and antimicrobial resistance rates in Jiangsu,China

Detailed Description

The study is a sample survey of the community population in cities of Jiangsu where the centers are located.The Helicobacter pylori infection and drug-resistant gene mutations are detected by real-time PCR performed on the stools of subjects.

Study Timeline

• Study First Submitted: 2022-12-08
• Study First Submitted QC: 2022-12-08
• Study First Posted: 2022-12-16
• Study Start: 2023-03-01
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-14
• Last Update Posted: 2023-08-16
• Primary Completion: 2023-08-30
• Study Completion: 2023-08-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 4000

Inclusion Criteria

1. community population
2. Fecal samples can be obtained, and the sample volume meets the requirements of the collection tube instructions
3. Only one person per family can be selected
4. Voluntarily participated in this study and signed an informed consent form

Exclusion Criteria

1. The collector does not cooperate or has poor compliance;
2. Adequate and qualified fecal samples could not be obtained;
3. Stool samples were collected during diarrhea or constipation;
4. Antibiotics, bismuth preparations, proton pump inhibitors and other Hp sensitive drugs have been used within one month.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu	2022.12.1-2023.6.30	the Helicobacter Pylori Infection rate in Jiangsu family

Secondary Outcome Measures

Name	Time	Method
Trends of Antimicrobial Resistance of Helicobacter Pylori in Jiangsu	2022.12.1-2023.6.30	resistance to antimicrobial agents applicable for H. pylori eradication

Trial Locations

Locations (16)

The 1st people's hospital of Lianyungang; 🇨🇳 Lianyungang, Jiangsu, China

Affiliated Hospital of Nantong University; 🇨🇳 Nantong, Jiangsu, China

The Affiliated Shuyang Hospital of Xuzhou Medical University; 🇨🇳 Suqian, Jiangsu, China

Changshu No.1 People's Hospital; 🇨🇳 Suzhou, Jiangsu, China

Affiliated Hospital of Yangzhou University; 🇨🇳 Yangzhou, Jiangsu, China

People's hospital of Yangzhong City; 🇨🇳 Zhenjiang, China

Nanjing First Hospital, Nanjing Medical University; 🇨🇳 Nanjing, Jiangsu, China

Changzhou Traditional Chinese medical hospital,Affiliated to Nanjing University of Chinese Medicine; 🇨🇳 Changzhou, Jiangsu, China

The First People's Hospital of Xuzhou, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University; 🇨🇳 Xuzhou, Jiangsu, China

Dongtai People's Hospital; 🇨🇳 Yancheng, Jiangsu, China

Rudong County People's Hospital; 🇨🇳 Nantong, Jiangsu, China

Affiliated Hospital of Jiangsu University; 🇨🇳 Zhenjiang, Jiangsu, China

JinHu county people's hospital; 🇨🇳 Huaian, Jiangsu, China

Department of Gastroenterology Wuxi People's Hospital Affiliated to Nanjing Medical University; 🇨🇳 Wuxi, Jiangsu, China

Yancheng First Hospital Affiliated Hospital of Nanjing University Medical School; 🇨🇳 Yancheng, Jiangsu, China

Changshu Hospital Affiliated to Nanjing University of Chinese Medicine; 🇨🇳 Suzhou, China